Skin Cancer

EP. 1: Case 1: 69-Year-Old Male With Locally Advanced cSCC

November 25th 2019

EP. 2: Case 1: Treatment Options for Locally Advanced cSCC

November 25th 2019

EP. 3: Case 1: Data Supporting Anti-PD-1 in cSCC

November 25th 2019

EP. 4: Case 1: Managing Patients With cSCC on Anti-PD-L1

November 25th 2019

EP. 5: Case 2: BRAF-Mutated Metastatic Melanoma

November 25th 2019

EP. 6: Case 2: Long-Term BRAF/MEK Data in Melanoma

November 25th 2019

EP. 7: Case 3: Recurrent Metastatic cSCC

November 25th 2019

EP. 8: Case 3: Practical Management of Metastatic CSCC

November 25th 2019

EP. 9: Case 4: Infiltrative Basal Cell Carcinoma

November 25th 2019

EP. 10: Case 4: Options Beyond HHI for Basal Cell Carcinoma

November 25th 2019

EP. 11: FDA Accepts sNDA for Photodynamic Therapy in Superficial Basal Cell Carcinoma

ByJonah Feldman

February 12th 2026

FDA accepts Ameluz PDT sNDA for superficial basal cell carcinoma, with strong phase 3 clearance data and a September 2026 decision deadline.